CVS Sept same-store sales up 5 percent

NEW YORK, July 10 (Reuters) - Pfizer Inc. (PFE.N) said on Tuesday that it had won a patent case over its Lipitor drug in an Irish court, which ruled a patent protecting the blockbuster cholesterol fighter would be infringed by a competing product from India's Ranbaxy Laboratories Ltd. (RANB.BO)

The decision, which is subject to a possible appeal, prevents Ranbaxy from launching its drug before the basic Lipitor patent expires in November 2011, Pfizer said.

((Reporting by Lewis Krauskopf; Reuters Messaging: Lewis.Krauskopf.reuters.com@reuters.net; lewis.krauskopf@reuters.com; 646-223-6082)) Keywords: PFIZER LIPITOR/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS5554